Physician profile
Richard J Eppey
NPI 1902112782
$11,190.54
in general payments reported to CMS, 2019-2025
13 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,272 · 2020: $3,125 · 2021: $3,160 · 2022: $220 · 2023: $142 · 2024: $151 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,181.55 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $222.26 | 2022-2025 | |
| Novo Nordisk INC | $186.27 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Daiichi Sankyo INC. | $124.51 | 2020 | |
| Pfizer INC. | $121.01 | 2024-2025 | |
| Hologic Sales and Service, LLC | $120.88 | 2019-2025 | Myosure Tissue Removal Device |
| Dexcom, INC. | $110.67 | 2023 | Dexcom G7 Gss (161) |
| Glaxosmithkline, LLC. | $31.68 | 2023-2024 | Shingrix, Bexsero, Arexvy |
| Astellas Pharma US INC | $23.98 | 2024 | Veozah |
| Mayne Pharma Commercial LLC | $20.02 | 2025 | |
| Abbvie INC. | $18.65 | 2021 | |
| Merck Sharp & Dohme LLC | $16.20 | 2021 | |
| Medtronic, INC. | $12.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Eppey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.